Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine for Relapsed B-Cell Chronic Lymphocytic Leukemia
NCT00005829Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Feb 2000
- Primary completion
- Oct 2002
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of gemcitabine in chronic lymphocytic leukemia (CLL), sponsored by Cancer and Leukemia Group B. Started Feb 2000; status: completed.
02
Drugs
gemcitabine
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00005829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005829.